Stay updated on Pediatric Galcanezumab for Episodic Migraine Clinical Trial

Sign up to get notified when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.2 and the older Revision: v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:49:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the study record history.
    Difference
    0.0%
    Check dated 2026-03-18T18:06:26.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:51:24.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 entry was added to the page history. The government funding lapse notice and the prior Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:00:39.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added a site-wide funding-lapse notice and updated the record revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-03T22:36:20.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2026-01-27T17:38:34.000Z thumbnail image

Stay in the know with updates to Pediatric Galcanezumab for Episodic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.